The independent path for myopia services

As myopia management services mature and become more widespread, many of the trailblazing products that boosted early-adaptors in the independent sector are now also available in some of the large chains.  

However, with more and more myopia management products launching to market, there is still plenty of scope for independent practices to differentiate from their multiple rivals.  

Independent ophthalmic lens lab Optimum Rx Group launched its new myopia management product, OptiMyope, in the first quarter of 2023.  

‘OptiMyope is a state-of-the-art myopia management solution for paediatric patients who are considered high risk for myopia progression and its associated pathologies,’ comments Mark Marland (pictured, left), sales director at Optimum Rx Group.